Assignee
DEUTERX LLC
US20 patents
Top patents by PatentIndex Score
US9732031B2Aug 15, 2017
Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
DEUTERX LLC121 citations97
US9833445B2Dec 5, 2017
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
DEUTERX LLC12 citations92
US9540340B2Jan 10, 2017
3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
DEUTERX LLC12 citations92
US9416117B2Aug 16, 2016
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
DEUTERX LLC12 citations92
US8969581B2Mar 3, 2015
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
DEUTERX LLC19 citations92
US9925175B2Mar 27, 2018
Deuterium-enriched pioglitazone
DEUTERX LLC7 citations84
US10202316B2Feb 12, 2019
3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
DEUTERX LLC4 citations83
US9809603B1Nov 7, 2017
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
DEUTERX LLC12 citations83
US9290475B2Mar 22, 2016
3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
DEUTERX LLC10 citations83
US8735454B2May 27, 2014
Deuterium-enriched bupropion
DEUTERX LLC4 citations73
US11535603B1Dec 27, 2022
Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using same
DEUTERX LLC4 citations72
US10189858B2Jan 29, 2019
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
DEUTERX LLC3 citations72
US10188639B2Jan 29, 2019
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
DEUTERX LLC3 citations72
US11820720B2Nov 21, 2023
3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deuteropiperidine-2,6-dione derivatives and compositions comprising and methods of using the same
DEUTERX LLC0 citations62
US11491156B2Nov 8, 2022
3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
DEUTERX LLC0 citations62
US11040925B2Jun 22, 2021
3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
DEUTERX LLC0 citations62
US9913845B2Mar 13, 2018
3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
DEUTERX LLC1 citations62
US12180137B1Dec 31, 2024
Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereof
DEUTERX LLC0 citations52
US8669275B2Mar 11, 2014
Deuterium-enriched donepezil
DEUTERX LLC1 citations52
US10555946B2Feb 11, 2020
3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
DEUTERX LLC0 citations51